Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Pharma & Bio
Lifestyle

Onconic Therapeutics Inc. “Zacubo,” Taken Without Water… Breaks into India and Sets Sights on China

#Onconic Therapeutics Inc.’s gastroesophageal reflux disease (GERD) treatment “Zacubo” has demonstrated, through clinical data, the competitiveness of its orally disintegrating tablet formulation, whi…
  • 2026-11-06 08:01:03
  • KIM JI-WAN
Technology

Shim Un-seop, Chairman of Graphy Inc.: “Our Next Move Is ‘3D-Printed Teeth’… Pushing Ahead with a Directly Operated Lab in Brazil”

#Graphy Inc. is expanding its so-called “tooth printing” business, which involves directly manufacturing dental prosthetics such as crowns and bridges using 3D printers. The company plans to develop “…
  • 2026-11-06 08:01:02
  • NA EUN-KYUNG
Technology

Fearing Hysterectomy, Women Postpone Uterine Fibroid Treatment… Da Vinci Opens the Door to Organ-Preserving Treatment [Expert Insight]

Pain and surgical costs aren’t the only reasons women delay treatment for uterine fibroids. Some patients avoid visiting the hospital altogether after being told they’ll need to have their uterus remo…
  • 2026-11-06 07:31:02
  • NA EUN-KYUNG
Technology

Lee Hak-jong, CEO of IMGT: Why He Is Investing 40 Billion Won to Pursue a Phase III Clinical Trial in the U.S.

IMGT, a developer of focused ultrasound-based cancer treatment medical devices, is set to embark on a large-scale confirmatory clinical trial following its designation as a Breakthrough Device (BDD) b…
  • 2026-11-05 10:02:02
  • KIM SAE-MI
Technology

ROKIT HEALTHCARE Inc. Hits a Snag in Colombia, Following Setbacks in the U.S.—Uncertainty Surrounding Overseas Operations Rises

(Graphic: ChatGPT) #ROKIT HEALTHCARE Inc.’s overseas organ regeneration platform business has run into regulatory hurdles. This comes after ROKIT HEALTHCARE Inc.’s U.S. distribution partner, Tizes…
  • 2026-11-05 07:31:02
  • Minji Son
Lifestyle

SK BIOPHARMACEUTICALS, GC Biopharma Corp., and Samsung BioLogics Defy the Market Downturn Amid a String of Positive News [Bio Spotlight]

On the 3rd, most domestic pharmaceutical and biotech stocks fell in the wake of a sharp market decline. Although the pharmaceutical sector index rose 0.03%, 124 of the 161 listed stocks fell, while on…
  • 2026-11-05 07:16:04
  • KIM JI-WAN
Technology

SK Biopharm’s Xcopri Launches in Korea With Insurance Coverage [K-Bio Pulse]

Most South Korean pharmaceutical and biotech stocks fell on November 3 as a broad market sell-off weighed on the sector. The pharmaceutical index edged up 0.03%, but declining stocks outnumbered gaine…
  • 2026-11-05 07:16:02
  • KIM JI-WAN
Lifestyle

[Report] “We’re currently packaging the treatment for the first patient”… BioGenCell, the first manufacturer under the Advanced Biotechnology Act

“What you’re seeing now is the process of packaging the finished product.” Workers at the BigenCell V-Cell Center manufacturing facility are carrying out the VT-EBV-N production process while weari…
  • 2026-11-05 07:11:02
  • KIM JI-WAN
Lifestyle

DaewonPharmaceutical’s ‘Felubi’ Expands Beyond Arthritis to Post-Surgical Pain… A Bold Move to Export to 18 Countries

DaewonPharmaceutical(003220) Daewon Pharmaceutical’s flagship new drug, “Felubi,” has demonstrated potential in pain management following knee replacement surgery. In a direct comparison with the wide…
  • 2026-11-05 07:01:03
  • KIM JI-WAN
Technology

Cell Therapy Reforms Put Vaxcell-Bio in the Spotlight [K-Bio Pulse]

South Korea’s pharmaceutical and life sciences indices moved in opposite directions on Nov. 2, even though gainers outnumbered decliners in both sectors. The pharmaceutical index fell 1.04% from the p…
  • 2026-11-04 08:02:03
  • KIM JI-WAN
1 2 3 4 5 6 7 8 9 10 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English